supports
-
Health
Study Supports High-Dose RT, Long-Term ADT as Standard for High-Risk Prostate Cancer
Meeting Coverage > GuCS — OS, PFS, cancer-specific survival all improved, with no increase in toxicity by Charles Bankhead, Senior…
Read More »